This review examined a collection of studies regarding the molecular properties of some polyene antibiotic molecules as well as their properties in solution and in particular environmental conditions. We also looked into the proposed mechanism of action of polyenes, where membrane properties play a crucial role. Given the interest in polyene antibiotics as therapeutic agents, we looked into alternative ways of reducing their collateral toxicity, including semi-synthesis of derivatives and new formulations. We follow with studies on the role of membrane structure and, finally, recent developments regarding the most important clinical applications of these compounds.
B lymphocytes are a leukocyte subset capable of developing several functions apart from differentiating into antibody‐secreting cells. These processes are triggered by external activation signals that induce changes in the plasma membrane properties, regulated by the formation of different lipid‐bilayer subdomains that are associated with the underlying cytoskeleton through different linker molecules, thus allowing the functional specialization of regions within the membrane. Among these, there are tetraspanin‐enriched domains. Tetraspanins constitute a superfamily of transmembrane proteins that establish lateral associations with other molecules, determining its activity and localization. In this study, we identified TSPAN33 as an active player during B‐lymphocyte cytoskeleton and plasma membrane‐related phenomena, including protrusion formation, adhesion, phagocytosis, and cell motility. By using an overexpression model of TSPAN33 in human Raji cells, we detected a specific distribution of this protein that includes membrane microvilli, the Golgi apparatus, and extracellular vesicles. Additionally, we identified diminished phagocytic ability and altered cell adhesion properties due to the aberrant expression of integrins. Accordingly, these cells presented an enhanced migratory phenotype, as shown by its augmented chemotaxis and invasion rates. When we evaluated the mechanic response of cells during fibronectin‐induced spreading, we found that TSPAN33 expression inhibited changes in roughness and membrane tension. Contrariwise, TSPAN33 knockdown cells displayed opposite phenotypes to those observed in the overexpression model. Altogether, our data indicate that TSPAN33 represents a regulatory element of the adhesion and migration of B lymphocytes, suggesting a novel implication of this tetraspanin in the control of the mechanical properties of their plasma membrane.
18 February 2023 in Journal of Applied Polymer Science
Polymers tend to have low surface free energy, a significant cause of adhesion properties with other substances. Plasma treatment is an optimal method to improve surface properties. This work used a recycled glass fiber‐polymer coating, and another based on Nylon 6,6. The surface modification of both layers was carried out with an atmospheric plasma treatment at different times. Chemical analysis of the plasma treated and the untreated surface were analyzed by infrared spectroscopy and X‐ray diffraction. Atomic force microscopy (AFM) investigated the morphology and topography surface. The plasma treatment results improve wettability and surface free energy. The contact angle decreases for Nylon 6,6 from 68° to 0° and for glass fiber‐polymer from 56° to 18°. However, the wettability remains over time in Nylon 6,6 layer, and the composite material reverts in 15 days. The high surface free energy after plasma treatment was mainly due to an increase in the polar component by inserting polar groups. The % crystallinity increases with plasma treatment due to the loss of the amorphous part of the polymer by plasma etching. AFM analysis shows an improvement in the roughness surface after treatment. These results greatly interest in enhancing adhesion with other substrates.
24 July 2023 in Journal of Applied Polymer Science
Polyhydroxybutyrate (P3HB) is a biocompatible polymer. However, its hydrophobic surface can disrupt cell adhesion, which is essential in implanted biomaterials. Atmospheric plasma treatment is an environmentally friendly method that improves surface properties. This study analyzed P3HB coatings obtained on stainless steel by various mechanical interlocking and their plasma process. The surface free energy and the degree of crystallinity of coatings increased with the plasma treatment. Atomic force microscopy analysis showed that roughness improved, and adhesion energy increased by a factor of three after plasma treatment by inserting polar groups analyzed with Raman spectroscopy. Based on this, a mechanism of chemical functionalization by plasma on the surface is proposed. The results depend on the initial properties given by the mechanical interlocking at the metal‐polymer interface.
Chagas Disease is a neglected tropical disease caused by the protozoan parasite Trypanosoma cruzi, affecting 6–8 million people, mainly in Latin America. The medical treatment is based on two compounds, benznidazole and nifurtimox, with limited effectiveness and that produce severe side effects; consequently, there is an urgent need to develop new, safe, and effective drugs. Amphotericin B is the most potent antimycotic known to date. A21 is a derivative of this compound with the property of binding to ergosterol present in cell membranes of some organisms. In the search for a new therapeutic drug against T. cruzi, the objective of this work was to study the in vitro and in vivo effects of A21 derivative on T. cruzi. Our results show that the A21 increased the reactive oxygen species and reduced the mitochondrial membrane potential, affecting the morphology, metabolism, and cell membrane permeability of T. cruzi in vitro. Even more important was finding that in an in vivo murine model of infection, A21 in combination with benznidazole was able to reduce blood parasitemia, diminish the immune inflammatory infiltrate in skeletal muscle and rescue all the mice from death due to a virulent T. cruzi strain.
20 February 2023 in Mundo Nano. Revista Interdisciplinaria en Nanociencias y Nanotecnología
Los liposomas son vesículas artificiales biocompatibles y biodegradables que poseen una estructura con dos compartimentos capaces de albergar moléculas hidrofílicas y lipofílicas, respectivamente. Los liposomas han sido ampliamente investigados durante los últimos veinte años como sistemas de liberación de fármacos, lo cual ha resultado en el desarrollo de diversas tecnologías como liposomas Stealth® y DepoFoam®. Asimismo, han surgido liposomas funcionalizados en su superficie con biomacromoléculas que pueden reconocer blancos biológicos específicos, dando lugar a potenciales terapias de alta selectividad. De igual manera, liposomas que responden a estímulos fisicoquímicos o biológicos y en los que la liberación de un fármaco estaría controlada en función de dicho estímulo. O bien, liposomas que encapsulan 2 o más fármacos, resultando así en terapias de combinación. Los liposomas son las primeras nanomedicinas en alcanzar uso clínico. Actualmente, existen al menos 20 tecnologías liposomales para tratar diversos padecimientos y alrededor de 18 están en fases clínicas de evaluación. La mayoría de liposomas comerciales se utilizan para tratar diferentes tipos de cáncer. Sin embargo, varias formulaciones liposomales para otros padecimientos han mostrado resultados prometedores. En este trabajo revisamos los conceptos básicos sobre liposomas, discutimos los casos de éxito y revisamos aquellas nanoformulaciones que se encuentran en estudios clínicos. Por último, por medio de ciencia de datos, presentamos el panorama actual de la investigación de liposomas en el área de la nanomedicina. Sin duda, los liposomas están y seguirán estando a la vanguardia en el traslado de nanotecnologías en beneficio de la salud de la población.